Skip to main navigation Skip to search Skip to main content

APOE-ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting

  • Lyzel S. Elias-Sonnenschein*
  • , Wolfgang Viechtbauer
  • , Inez Ramakers
  • , Obioha Ukoumunne
  • , Frans R.J. Verhey
  • , Pieter Jelle Visser
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: Our primary objective is to determine the diagnostic accuracy of the APOE-ε4 allele in detecting AD dementia and other types of dementia in people with MCI in a secondary care setting. Our secondary objective is to investigate the following potential sources of heterogeneity of test accuracy, where reported: characteristics of participants, namely, baseline MMSE score, age, and gender; APOE-ε4 background prevalence; MCI definition; length of follow-up; and reference standards.

Original languageEnglish
Article numberCD010950
JournalCochrane Database of Systematic Reviews
Volume2014
Issue number1
DOIs
Publication statusPublished - 31 Jan 2014

Fingerprint

Dive into the research topics of 'APOE-ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting'. Together they form a unique fingerprint.

Cite this